Gala Health vs Revel Health

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Gala Health

Affiliate partner

Women who have already committed to a full year and want one all-doses-included rate — plus, unusually, an HRT and menopause line running on the same account as the weight program.

Semaglutide / month: From $129/moCompounded (plan length not stated); brand Ozempic $1,299/mo
Tirzepatide / month: $179/moYearly subscription; $199/mo on a 3-month plan

Index 71/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Gala Health pricing Read review

Revel Health

Provider comparison

Revel Health's site is behind a password page, so it isn't taking patients or orders right now.

Semaglutide / month: $199/moStarting dose, promotional rate, compounded
Tirzepatide / month: $249/moStarting dose, compounded

Unavailable · Not scoredChecked October 2026

Revel Health's site is behind a password page, so it isn't taking patients or orders right now.

Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

This pair includes a provider that is unavailable for direct GLP-1 enrollment. We do not declare a score winner or compare factor scores when either provider is unavailable.

Revel Health: Revel Health's site is behind a password page, so it isn't taking patients or orders right now.

Check the difference in state access

Gala Health: 50 states claimed, no list published
Revel Health: 45 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Gala Health

Revel Health

Semaglutide / month: Gala Health: From $129/moCompounded (plan length not stated); brand Ozempic $1,299/mo; Revel Health: $199/moStarting dose, promotional rate, compounded

Tirzepatide / month: Gala Health: $179/moYearly subscription; $199/mo on a 3-month plan; Revel Health: $249/moStarting dose, compounded

Semaglutide / year (modeled): Gala Health: —; Revel Health: $2,388

Tirzepatide / year (modeled): Gala Health: $2,148; Revel Health: $2,988

State availability: Gala Health: 50 states claimed, no list published; Revel Health: 45 states

Oral / sublingual option listed: Gala Health: Not listed; Revel Health: Not listed

Brand-name access listed: Gala Health: Yes; Revel Health: Not confirmed

Provider facts checked: Gala Health: October 2026; Revel Health: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

Review the access limitations and recorded program details. Availability comes before choosing a treatment plan.

Gala Health

Women who have already committed to a full year and want one all-doses-included rate — plus, unusually, an HRT and menopause line running on the same account as the weight program.

Reasons to consider it

$179/mo on a yearly subscription, with every dose included, so the price does not climb as you titrate — dose escalation is where most flat-looking programs quietly get expensive
The price list is public and un-gated: the compounded tier and the brand tier are both printed before any quiz, intake or email capture
Both compounded molecules — semaglutide and tirzepatide — prescribable on one account

What to weigh up

No month-to-month price exists anywhere on the site. "FROM $179/month" sits directly above "All doses included. Yearly subscription.", and the cheapest alternative the FAQ names is "$199 per month (with a 3-month plan)" — three months is the shortest published commitment there is
$179/mo is $2,148 committed for the year, and that total is printed nowhere, which makes it hard to compare with a price you can cancel next month
Compounded semaglutide is advertised from $129 a month, but the plan length behind that figure isn't shown before checkout

Compounded drugs are not FDA-approved. Understand the medication options.

Check Gala Health pricing Read the full Gala Health review

Revel Health

Revel Health's site is behind a password page, so it isn't taking patients or orders right now.

Provider background

All-in pricing: consultation, medication, supplies and shipping in one number, with no add-on fees disclosed
LegitScript verification seal is live and checkable for Revel Health's own site
Explicit, specific 45-state coverage list published rather than a vague claim

What to weigh up

The prominently displayed $99/$149 figures are first-month-only promotional prices — the standing rate from month two on is $199/$249, and the page's side-by-side display makes the promo easy to mistake for the ongoing price
Not available in AK, AR, NC, NJ, or MS
No named medical director or individual prescriber — the pharmacy is described only as a 'USP-certified facility' with no name given

Revel Health's site is behind a password page, so it isn't taking patients or orders right now.

Read the full Revel Health review

Before you sign up

Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to Gala Health Alternatives to Revel Health

More provider matchups

CoreAge Rx vs Gala Health CoreAge Rx vs Revel Health

Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.